Can a subgroup at high risk for LRR be identified from T1-2 breast cancer with negative lymph nodes after mastectomy? A meta-analysis
- PMID: 31484798
- PMCID: PMC6753322
- DOI: 10.1042/BSR20181853
Can a subgroup at high risk for LRR be identified from T1-2 breast cancer with negative lymph nodes after mastectomy? A meta-analysis
Abstract
Purpose: To identify a subgroup at high risk for loco-regional recurrence (LRR) from T1-2 breast cancer with negative lymph nodes (N0) after mastectomy by using a meta-analysis.Methods and materials: Published studies on the relationship between clinical features and LRR of breast cancer were identified from public databases, including PubMed, EMBASE, and the Cochrane Library. High-risk features for LRR in this patient population were defined based on the pooled results of meta-analysis.Results: For the meta-analysis, a total of 11244 breast cancers with pT1-2N0 after mastectomy from 20 publications were included for analysis. The pooled results indicated that age (hazard ratio (HR) 1.77, P=0.001), lymphovascular invasion (LVI) (HR 2.23, P<0.001), histologic grade (HR 1.66, P<0.001), HER2 status (HR 1.65, P=0.027), menopausal status (HR 1.36, P=0.015), and surgical margins (HR 2.56, P=0.014) were associated with a significantly increased risk of developing LRR in this patient population group, but not for tumor size (HR 1.32, P=0.23), systematic therapy (HR 1.67, P=0.20), and hormonal receptor status (HR 1.04, P=0.73).Conclusion: In the current study, patients with young age, positive LVI, high histologic grade, HER-2 positive, premenopausal, and positive surgical margins have an increased risk of developing LRR. Further prospective trials are needed to clearly define the role of adjuvant postmastectomy radiotherapy in T1-2N0 breast cancer at high risk of developing LRR.
Keywords: PMRT; breast cancer; local recurrence; risk factors.
© 2019 The Author(s).
Conflict of interest statement
The authors declare that there are no competing interests associated with the manuscript.
Figures
Similar articles
-
Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?Cancer. 2017 Jul 15;123(14):2626-2633. doi: 10.1002/cncr.30658. Epub 2017 Mar 23. Cancer. 2017. PMID: 28334423 Free PMC article.
-
Indications for Postmastectomy Radiation After Neoadjuvant Chemotherapy in ypN0 and ypN1-3 Axillary Node-Positive Women.Clin Breast Cancer. 2018 Feb;18(1):e107-e113. doi: 10.1016/j.clbc.2017.07.016. Epub 2017 Aug 1. Clin Breast Cancer. 2018. PMID: 28830795
-
Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1337-47. doi: 10.1016/j.ijrobp.2004.08.009. Int J Radiat Oncol Biol Phys. 2005. PMID: 15817335
-
Radiotherapy after skin-sparing mastectomy with immediate breast reconstruction in intermediate-risk breast cancer : Indication and technical considerations.Strahlenther Onkol. 2019 Nov;195(11):949-963. doi: 10.1007/s00066-019-01507-9. Epub 2019 Aug 26. Strahlenther Onkol. 2019. PMID: 31451835 Review. English.
-
Post-mastectomy radiation therapy in breast cancer patients with 1-3 positive lymph nodes: No one size fits all.Crit Rev Oncol Hematol. 2020 Mar;147:102880. doi: 10.1016/j.critrevonc.2020.102880. Epub 2020 Jan 18. Crit Rev Oncol Hematol. 2020. PMID: 32045847 Review.
References
-
- McGale P., Taylor C., Ebctcg et al. (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383, 2127–2135 10.1016/S0140-6736(14)60488-8 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous